RT-PCR 시장 규모와 예측(2021-2031년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 - 제품별, 용도별, 최종사용자별
RT-PCR Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End user
상품코드:1938275
리서치사:The Insight Partners
발행일:2026년 01월
페이지 정보:영문 274 Pages
라이선스 & 가격 (부가세 별도)
한글목차
새로운 시장 조사 보고서 "RT-PCR 시장 예측(-2031년) - 세계 분석 - 제품별, 용도별, 최종사용자별"에 따르면 RT-PCR 시장 규모는 2024년 27억 1,000만 달러에서 2031년까지 44억 7,000만 달러로 성장할 것으로 예측됩니다. 2025-2031년 연평균 복합 성장률(CAGR) 7.5%를 나타낼 것으로 예측됩니다. RT-PCR 시장의 성장 요인으로는 고감도 및 고정밀 핵산 검출에 대한 수요, 임상 진단 및 개인 맞춤형 의료의 적용 범위 확대, RT-PCR 기술 및 자동화의 발전 등을 꼽을 수 있습니다.
역전사 중합효소 연쇄반응(RT-PCR)은 역전사를 통해 RNA를 상보적 DNA(cDNA)로 변환하고, PCR로 증폭하여 RNA를 검출 및 측정하는 실험실 기술입니다. 높은 민감도와 특이성으로 바이러스 검출, 유전자 발현 분석, 분자진단에 널리 활용되고 있습니다. RT-PCR은 코로나19 팬데믹에서 SARS-CoV-2 감염을 확인하는 데 매우 중요한 역할을 했습니다. 이 기술은 질병의 조기 발견, 바이러스 양 모니터링, 유전자 활성도 조사를 가능하게 하며, 전 세계 임상 진단, 생의학 연구, 공중 보건 모니터링에 필수적인 도구가 되고 있습니다.
RT-PCR 시장 보고서의 지역적 범위에는 북미, 유럽, 아시아태평양, 중남미, 중동 및 아프리카 시장 동향 평가가 포함됩니다. 북미 RT-PCR 시장은 빠르고 정확한 진단 검사에 대한 지속적인 수요, 특히 최근 감염병 사태로 인해 더욱 두드러지게 나타나고 있습니다. 미국 질병통제예방센터(CDC)는 2022년까지 1억 2,000만 건 이상의 COVID-19 확진자가 발생할 것으로 예상하고 있으며, 이는 전염병 관리에서 RT-PCR 검사의 중요한 역할을 강조하고 있습니다. CDC와 FDA의 보고서에 따르면 2023년과 2024년에도 COVID-19의 확산 상황은 검사 전략에 계속 영향을 미칠 것이며, 바이러스 확산을 감시하고 통제하기 위해 매월 수백만 건의 검사가 수행된 것으로 추정됩니다. 또한 독감, 호흡기세포융합바이러스(RSV) 등 기타 감염성 질환의 발생률 증가는 검사 수요를 더욱 증가시키고 있습니다.
RT-PCR 시장 전망에 따르면 감염률 증가와 진단 기술의 발전으로 인해 향후 수년간 아시아태평양이 가장 빠른 성장을 기록할 것으로 예측됩니다. 세계보건기구(WHO)에 따르면 이 지역에서는 2022년 약 7억 건의 감염 사례가 보고될 것으로 예상되며, 특히 인도와 중국 등의 국가에서 도시화와 인구 밀도 증가로 인해 앞으로도 증가 추세가 지속될 것으로 전망하고 있습니다. 인도 보건가족복지부는 2023년 초에 20만 건이 넘는 COVID-19 신규 확진자가 발생했다고 보고했으며, 이는 효과적인 진단 솔루션에 대한 수요가 지속적으로 증가하고 있음을 보여줍니다. 2024년까지 RT-PCR 검사의 필요성은 지속될 것으로 예상되며, 특히 호흡기 감염이 심각한 건강 문제로 남아있으므로 RT-PCR 검사의 필요성은 지속될 것으로 예측됩니다.
바이오마커 기반 맞춤 의료를 위한 종양학 분야에서의 RT-PCR의 통합은 미래 시장 기회를 제공합니다.
세계보건기구(WHO)에 따르면 전 세계 신규 암 발병 건수는 2022년 2,000만 건, 2023년 2,030만 건, 2024년 2,050만 건으로 증가할 것으로 예측했습니다. RT-PCR 기술을 통해 60%의 사례에서 표적 치료를 위한 암 유전자 프로파일링이 가능해졌습니다. 미국에서는 국립암연구소(NCI)가 2022년 190만 건의 신규 사례를 보고하고, 2023년에는 200만 건, 2024년에는 204만 1,000건으로 증가할 것으로 예측했습니다. RT-PCR은 70%의 정밀의료 시험에서 바이오마커를 검증했습니다. 유럽에서는 유럽암정보시스템(ECIS)에 따르면 EU 27개국에서 2022년 274만 건으로 추정되며, 2023년 278만 건, 2024년 282만 건으로 증가할 것으로 예측됩니다. RT-PCR은 폐암 진단의 50%에서 유전자 융합 검사를 가능하게 합니다.
최근 제품 개발로는 2023년 종양학 패널을 확대한 가드앤트헬스의 RT-PCR 기반 액체생검 '가드앤트 리빌'이 2024년 8월 대장암 재발 검출용으로 FDA 승인을 획득했습니다. 또한 유럽의약품청(EMA)은 2023년 로슈의 RT-PCR 기반 유전자 융합 검사 '파운데이션 원 CDx'를 승인했습니다. 다른 사례로는 미국 국립보건원(NIH)이 2024년 정밀종양학에 2억 달러를 배정했다는 점을 들 수 있습니다. 2023년에는 500건의 연구에서 RT-PCR을 통한 바이오마커를 검증하여 표적 치료의 정확도를 25% 향상시켰습니다. 이러한 혁신은 동반진단에서 RT-PCR의 가능성을 보여주며, 개인 맞춤형 암 치료의 발전에 기여하고 있습니다.
목차
제1장 도입
제2장 개요
제3장 조사 방법
제4장 RT-PCR 시장 구도
제5장 RT-PCR 시장 - 주요 업계 동향
제6장 RT-PCR 시장 - 세계 시장 분석
제7장 세계의 RT-PCR 시장 - 매출과 예측 - 제품별
제8장 세계의 RT-PCR 시장 - 2031년까지의 매출과 예측 - 용도별
제9장 세계의 RT-PCR 시장 - 2031년까지의 매출과 예측 - 최종사용자별
제10장 RT-PCR 시장 - 지역 분석
제11장 RT-PCR 시장의 업계 상황
제12장 기업 개요
제13장 부록
KSA
영문 목차
영문목차
According to our new research study on "RT-PCR Market Forecast to 2031 -Global Analysis - by Product, Application, and End User," the market is anticipated to grow from US$2.71 billion in 2024 to US$4.47 billion by 2031; the market is expected to register a CAGR of 7.5% from 2025 to 2031. The RT-PCR Market growth is attributed to the demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in RT-PCR technology and automation.
Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a laboratory technique used to detect and measure RNA by converting it into complementary DNA (cDNA) through reverse transcription, followed by amplification using PCR. It is widely used for viral detection, gene expression analysis, and molecular diagnostics because of its high sensitivity and specificity. RT-PCR played a critical role during the COVID-19 pandemic for identifying SARS-CoV-2 infections. The technique enables early disease detection, monitoring of viral load, and research into genetic activity, making it an essential tool in clinical diagnostics, biomedical research, and public health surveillance worldwide.
The geographical scope of the RT-PCR market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. The North America RT-PCR market is propelled by the ongoing demand for rapid and accurate diagnostic testing, especially highlighted by recent infectious disease outbreaks. In the US, the CDC reported over 120 million COVID-19 cases by 2022, emphasizing the crucial role of RT-PCR testing in managing the pandemic. According to the CDC and FDA reports, the prevalence of COVID-19 continued to influence testing strategies in 2023 and 2024, with estimates indicating that millions of tests were conducted monthly to monitor and control the virus's spread. Additionally, the increasing incidence of other infectious diseases, such as influenza and respiratory syncytial virus (RSV), has further boosted testing demand.
The RT-PCR market outlook indicates that Asia Pacific is expected to register the fastest growth in the coming years, supported by increasing incidence of infectious diseases and advancements in diagnostic technologies. According to the World Health Organization (WHO), the region reported nearly 700 million cases of infectious diseases in 2022, with projections indicating continued upward trends due to urbanization and population density, especially in countries such as India and China. In India, the Ministry of Health and Family Welfare reported over 200,000 new COVID-19 cases in early 2023, underlining the ongoing demand for effective diagnostic solutions. By 2024, the requirement for RT-PCR testing is expected to persist, particularly as respiratory infections continue to pose significant health challenges.
Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine to Provide Market Opportunities in Future
According to the World Health Organization (WHO), global cancer incidence reached 20 million new cases in 2022, rising to 20.3 million in 2023 and 20.5 million in 2024, with RT-PCR enabling oncogene profiling in 60% of cases for targeted therapies. In the US, the National Cancer Institute (NCI) reported 1.9 million new cases in 2022, increasing to 2.0 million in 2023 and 2.041 million in 2024, where RT-PCR validated biomarkers in 70% of precision trials. In Europe, the European Cancer Information System (ECIS) estimated 2.74 million new cases in the EU-27 in 2022, rising to 2.78 million in 2023 and 2.82 million in 2024, with RT-PCR facilitating gene fusion testing in 50% of lung cancer diagnoses.
Recent product developments include the FDA's approval of Guardant Health's Guardant Reveal, an RT-PCR-based liquid biopsy for detecting colorectal cancer recurrence, in August 2024, following the company's oncology panel expansion in 2023. Additionally, the European Medicines Agency (EMA) authorized Roche's FoundationOne CDx in 2023 for RT-PCR-based gene fusion testing. Other instances encompass the NIH's 2024 allocation of US$200 million for precision oncology, where RT-PCR validated biomarkers in 500 studies in 2023, improving targeted therapy accuracy by 25%. These innovations present opportunities for RT-PCR in companion diagnostics, advancing tailored cancer care.
World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the RT-PCR Market report.
Table Of Contents
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. RT-PCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. RT-PCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Surging Global Infectious Disease Outbreaks Necessitating Rapid Diagnostic Capabilities
5.1.2 Escalating Cancer Incidence Driving Oncogene Detection and Personalized Diagnostics
5.1.3 Advancing Genetic Testing for Precision Medicine and Hereditary Disorders
5.2 Market Restraints
5.2.1 High Costs and Limited Accessibility of RT-PCR Testing Kits
5.2.2 Supply Chain Disruptions and Shortage of Reagents and Consumables
5.2.3 Regulatory Challenges and Lengthy Approval Processes
5.3 Market Opportunities
5.3.1 Expansion in Point-of-Care RT-PCR for Rapid Infectious Disease Response
5.3.2 Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine
5.3.3 Advancements in RT-PCR for Genetic Screening and Precision Health
5.4 Future Trends
5.4.1 Increasing Adoption of Multiplex RT-PCR Assays
5.4.2 Integration of Point-of-Care and Portable RT-PCR Devices
5.4.3 Advances in Automated and High-Throughput RT-PCR Technologies
5.5 Impact Analysis:
6. RT-PCR Market - Global Market Analysis
6.1 RT-PCR Market Revenue (US$ Mn), 2021 - 2031
7. Global RT-PCR Market - Revenue and Forecast to 2031 - by Product
7.1 Overview
7.2 RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
8. Global RT-PCR Market - Revenue and Forecast to 2031 - by Application
8.1 Overview
8.2 RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
8.4.2.1 RT-PCR Market, by Clinical Application, 2021-2031 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
9. Global RT-PCR Market - Revenue and Forecast to 2031 - by End-User
9.1 Overview
9.2 RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
10. RT-PCR Market - Geographical Analysis
10.1 North America RT-PCR Market, Revenue and Forecast To 2031
10.1.1 Overview
10.1.2 North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.3 North America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.1.4 North America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.1.4.1 North America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5 North America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.1 North America RT-PCR Market, by Country
10.1.5.2 US
10.1.5.2.1 US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.2.2 US: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.2.3 US: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.2.4.1 US: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.2.5 US: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.3.2 Canada: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.3.3 Canada: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.3.4.1 Canada: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.3.5 Canada: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.4.2 Mexico: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.4.3 Mexico: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.4.3.1 Mexico: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.4.4 Mexico: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2 Europe RT-PCR Market, Revenue and Forecast to 2031
10.2.1 Overview
10.2.2 Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.3 Europe: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.4 Europe: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.4.1 Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5 Europe: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.1 Europe RT-PCR Market, by Country
10.2.5.2 UK
10.2.5.2.1 UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.2.2 UK: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.2.3 UK: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.2.3.1 UK: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.2.4 UK: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.3 Germany
10.2.5.3.1 Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.3.2 Germany: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.3.3 Germany: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.3.3.1 Germany: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.4 Germany: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.4 France
10.2.5.4.1 France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.4.2 France: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.4.3 France: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.4.3.1 France: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.4.4 France: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.5 Italy
10.2.5.5.1 Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.5.2 Italy: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.5.3 Italy: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.5.3.1 Italy: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.5.4 Italy: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.6 Spain
10.2.5.6.1 Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.6.2 Spain: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.6.3 Spain: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.6.3.1 Spain: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.5 Spain: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.7 Rest of Europe
10.2.5.7.1 Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.7.2 Rest of Europe: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.7.3 Rest of Europe: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.7.3.1 Rest of Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.7.4 Rest of Europe: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3 Asia Pacific RT-PCR Market, Revenue and Forecast to 2031
10.3.1 Overview
10.3.2 Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.3 Asia Pacific: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.4 Asia Pacific: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.4.1 Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5 Asia Pacific: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.1 Asia Pacific RT-PCR Market, by Country
10.3.5.2 China
10.3.5.2.1 China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 China: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.2.3 China: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.2.3.1 China: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 China: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.3 Japan
10.3.5.3.1 Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 Japan: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.3.3 Japan: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.3.3.1 Japan: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.4 Japan: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.4 India
10.3.5.4.1 India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 India: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.4.3 India: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.4.3.1 India: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 India: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.5 Australia
10.3.5.5.1 Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Australia: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.5.3 Australia: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.5.3.1 Australia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Australia: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.6 South Korea
10.3.5.6.1 South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.6.2 South Korea: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.6.3 South Korea: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.6.3.1 South Korea: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.6.4 South Korea: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.7 Rest of Asia Pacific
10.3.5.7.1 Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.7.2 Rest of Asia Pacific: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.7.3 Rest of Asia Pacific: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.7.3.1 Rest of Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.7.4 Rest of Asia Pacific: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.4 Middle East & Africa RT-PCR Market, Revenue and Forecast to 2031
10.4.1 Overview
10.4.2 Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.4.3 Middle East & Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.4.4 Middle East & Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.4.4.1 Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.4.5 Middle East & Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.1 Middle East & Africa RT-PCR Market, by Country
10.3.5.2 Saudi Arabia
10.3.5.2.1 Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 Saudi Arabia: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.2.3 Saudi Arabia: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.2.3.1 Saudi Arabia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 Saudi Arabia: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.3 UAE
10.3.5.3.1 UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 UAE: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.3.3 UAE: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.3.3.1 UAE: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.5 UAE: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.4 South Africa
10.3.5.4.1 South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 South Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.4.3 South Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.4.3.1 South Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 South Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.5 Rest of Middle East & Africa
10.3.5.5.1 Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Rest of Middle East & Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.5.3 Rest of Middle East & Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.5.3.1 Rest of Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Rest of Middle East & Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.5 South & Central America RT-PCR Market, Revenue and Forecast to 2031
10.5.1 Overview
10.5.2 South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.3 South & Central America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.5.4 South & Central America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.5.4.1 South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5 South & Central America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.1 South & Central America RT-PCR Market, by Country
10.5.5.2 Brazil
10.5.5.2.1 Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.2.2 Brazil: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.2.3 Brazil: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.2.3.1 Brazil: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.2.4 Brazil: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.3 Argentina
10.5.5.3.1 Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.3.2 Argentina: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.3.3 Argentina: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.3.3.1 Argentina: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.3.4 Argentina: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.4 Rest of South & Central America
10.5.5.4.1 Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.4.2 Rest of South & Central America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.4.3 Rest of South & Central America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.4.3.1 Rest of South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.4.4 Rest of South & Central America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
